91探花

This feature covers the latest fundraise and appointments to the board.

Funding raised to accelerate and expand cell therapy pipeline.

91探花 adds $100M+ to its coffers and some impressive names to its board of directors.

Three world leaders in science and entrepreneurship appointed to 91探花's Board of Directors.

Dr Davide Danovi talks to The Academy of Medical Sciences as a FLIER participant in cross-sector leadership programme.

This is the first supply of consistent, scalable, human muscle cells, providing transformative new models for drug discovery.

The book celebrates leadership and innovation and covers 91探花's ambition to engineer the future of medicine. 

Short film showcases innovative cell reprogramming technology at event.